Asia Pacific Clinical Reference Laboratory Market

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)

No. of Pages: 93    |    Report Code: BMIRE00030828    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Clinical Reference Laboratory Market
Free Sample Buy Now

The Asia Pacific clinical reference laboratory market was valued at US$ 9,814.13 million in 2023 and is expected to reach US$ 16,510.17 million by 2031; it is estimated to register a CAGR of 6.7% from 2023 to 2031.

Strategic Initiatives with Reference Laboratories Boost Asia Pacific Clinical Reference Laboratory Market



Strategic initiatives by the laboratory service providers such as acquisition, alliance, and expansion with reference labs are among the most cost-effective ways to obtain the benefits of better patient care and cost efficiency. In 2024, Hausen-Bernstein Co. Ltd., the leading supplier of in-vitro diagnostic ("IVD") products in Thailand, was acquired by Everlife Holdings Pte Ltd, a prominent market access and distribution business in India and Southeast Asia. In 2024, CORE Diagnostics, a next-generation diagnostics for medication selection and disease stratification based in India, announced its plans to expand operations in 50 new cities. In 2023, Suburban Diagnostics opened its largest 'reference' laboratory in Vidya Vihar, Mumbai. This ultramodern laboratory will utilize state-of-the-art testing and process automation technologies to provide a comprehensive test menu for accurate and quick diagnosis. In 2023, TRUSTlab Diagnostics, a clinical reference laboratory in Hyderabad, India, partnered with NKV Path Labs in Gurugram to expand its diagnostic services to underserved areas of the nation. Thus, the increasing number of acquisitions and alliances with reference laboratories is expected to offer significant opportunities for market growth.

Asia Pacific Clinical Reference Laboratory Market Overview



In recent decades, the emergence of several infectious illnesses, including COVID-19 and monkeypox, has posed a new risk to human health. China has experienced a rapid epidemiological change, with notable advances in infectious disease control. When dealing with infectious disease concerns, it is critical to detect and locate the outbreak as soon as possible, identify the pathogen, and ensure proper disposal to minimize escalation and prevent and manage infectious diseases. Various tests are done in hospitals or reference laboratories to detect the pathogen. According to the provincial-level administrative divisions (PLADs), 5,770 malaria cases were recorded between 2014 and 2021, with 99.05% samples of malaria submitted to provincial malaria diagnosis reference laboratories. Provincial malaria diagnosis reference laboratories have played a critical role in guaranteeing the accuracy and reliability of Plasmodium diagnosis in healthcare facilities. The abovementioned factors are driving the clinical reference laboratory market in the country.

Asia Pacific Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million)
Get more information on this report

Asia Pacific Clinical Reference Laboratory Strategic Insights

Strategic insights for the Asia Pacific Clinical Reference Laboratory provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/asia-pacific-clinical-reference-laboratory-market-strategic-framework.webp
Get more information on this report

Asia Pacific Clinical Reference Laboratory Report Scope

Report Attribute Details
Market size in 2023 US$ 9,814.13 Million
Market Size by 2031 US$ 16,510.17 Million
Global CAGR (2023 - 2031) 6.7%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Service Provider
  • Hospital-Based
  • Standalone
  • Clinic-Based
By Application
  • Laboratory Medicine
  • Clinical Trials
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Sonic Healthcare Ltd
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • Myraid Genetics Inc
    		•
    Get more information on this report

    Asia Pacific Clinical Reference Laboratory Regional Insights

    The geographic scope of the Asia Pacific Clinical Reference Laboratory refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/asia-pacific-clinical-reference-laboratory-market-geography.webp
    Get more information on this report

    Asia Pacific Clinical Reference Laboratory Market Segmentation 



    The Asia Pacific clinical reference laboratory market is categorized into service provider, application, and country.

    Based on service provider, the Asia Pacific clinical reference laboratory market is segmented into hospital-based, standalone, and clinic-based. The hospital-based segment held the largest market share in 2023.

    In terms of application, the Asia Pacific clinical reference laboratory market is categorized into laboratory medicine, clinical trials, and others. The laboratory medicine segment held the largest market share in 2023.

    By country, the Asia Pacific clinical reference laboratory market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific clinical reference laboratory market share in 2023.

    Sonic Healthcare Ltd, Laboratory Corp of America Holdings, Quest Diagnostics Inc, and Myraid Genetics Inc are some of the leading companies operating in the Asia Pacific clinical reference laboratory market.

    Identical Market Reports with other Region/Countries

    The List of Companies - Asia Pacific Clinical Reference Laboratory Market

    1. Sonic Healthcare Ltd
    2. Laboratory Corp of America Holdings
    3. Quest Diagnostics Inc
    4. Myraid Genetics Inc
    Frequently Asked Questions
    How big is the Asia Pacific Clinical Reference Laboratory Market?

    The Asia Pacific Clinical Reference Laboratory Market is valued at US$ 9,814.13 Million in 2023, it is projected to reach US$ 16,510.17 Million by 2031.

    What is the CAGR for Asia Pacific Clinical Reference Laboratory Market by (2023 - 2031)?

    As per our report Asia Pacific Clinical Reference Laboratory Market, the market size is valued at US$ 9,814.13 Million in 2023, projecting it to reach US$ 16,510.17 Million by 2031. This translates to a CAGR of approximately 6.7% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Clinical Reference Laboratory Market report typically cover these key segments-

  • Service Provider (Hospital-Based, Standalone, Clinic-Based)
  • Application (Laboratory Medicine, Clinical Trials)

    • What is the historic period, base year, and forecast period taken for Asia Pacific Clinical Reference Laboratory Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Clinical Reference Laboratory Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in Asia Pacific Clinical Reference Laboratory Market?

    The Asia Pacific Clinical Reference Laboratory Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Sonic Healthcare Ltd
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • Myraid Genetics Inc
    • Who should buy this report?

    The Asia Pacific Clinical Reference Laboratory Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Clinical Reference Laboratory Market value chain can benefit from the information contained in a comprehensive market report.

    asia-pacific-clinical-reference-laboratory-market